Larvol Delta - Acute-Myeloid-Leukemia-2021-Perspectives-on-Testing-Systemic-Therapies-and-Transplantation-Episode-3-The-Role-of-FLT3-Inhibitors-for-Treatment-of-AML

lestaurtinib (CEP-701) - Teva, Kyowa Kirin

Rydapt (midostaurin) - Novartis

crenolanib besylate (ARO-002) - AROG

https://www.onclive.com/view/the-role-of-flt3-inhibitors-for-treatment-of-aml

Jul 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next